OnCo
peoplePerson

Dawn L. Hershman

Breast oncologist who co-leads SWOG and studies adherence, toxicity, and how care is actually delivered.

Dawn Hershman is a medical oncologist and health outcomes researcher. Co-chairs SWOG with Primo Lara. Led SWOG's cancer care delivery research and trials on chemotherapy-induced neuropathy and endocrine therapy adherence.

Role
Group Co-Chair, SWOG Cancer Research Network; Professor of Medicine and Epidemiology, Columbia University
Specialisms
Breast cancerCancer care deliverySurvivorship

Papers

2top
TitleJournalYear
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical TrialJAMA2018
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsJournal of Clinical Oncology2010

Connected

4top

cancers

2
HR-positive / HER2-negative breast cancerTriple-negative breast cancer (TNBC)

institutions

2
Herbert Irving Comprehensive Cancer Center, Columbia UniversitySWOG Cancer Research Network